Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Filings indexed 2,308 across all filing types
Latest filing 2017-04-24 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions under Novozymes' stock buyback program, providing accumulated figures and daily transaction breakdowns (number of shares, average price, transaction value) for April 18-21, 2017. The core subject is the company repurchasing its own shares. This directly matches the definition for 'Transaction in Own Shares' (Code: POS). It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K), but a specific disclosure about capital management via share repurchase.
2017-04-24 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 91% confidence The text reports that Novozymes has purchased its own shares under a stock buyback program, detailing the number of shares repurchased and the transaction value. This is a classic ‘Transaction in Own Shares’ announcement (buyback of treasury stock), fitting the POS category.
2017-04-24 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document is a company announcement from Novozymes dated April 24, 2017, detailing transactions related to its share buy-back program. It includes specific data on the number of shares repurchased, average purchase prices, and total transaction values. The text references compliance with EU regulations on market abuse and provides detailed trading data. There is no indication of financial statements, earnings results, management commentary, or other report types. The content is focused on the company's repurchase of its own shares, which fits the category of a Transaction in Own Shares (POS). The document length is substantial and contains detailed transaction data, confirming it is not a mere announcement of a report but the actual transaction disclosure.
2017-04-24 English
Director's Dealing 2017
Director's Dealing
2017-04-18 Danish
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 100% confidence The document explicitly details transactions under a 'stock buyback program' conducted by Novozymes, reporting the number of shares purchased, transaction values, and specific dates (April 10-14, 2017). This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The classification code for this is POS.
2017-04-18 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 92% confidence The text reports Novozymes’ purchase of its own shares under a buyback program, matching the definition of a transaction in own shares (share repurchase).
2017-04-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.